Mascoma Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35
Closed -$4.98K 456
2024
Q2
$4.98K Hold
35
﹤0.01% 410
2024
Q1
$3.9K Hold
35
﹤0.01% 400
2023
Q4
$4.54K Hold
35
﹤0.01% 398
2023
Q3
$5.71K Hold
35
﹤0.01% 381
2023
Q2
$6.21K Hold
35
﹤0.01% 370
2023
Q1
$4.14K Hold
35
﹤0.01% 495
2022
Q4
$2.78K Buy
+35
New +$2.47K ﹤0.01% 547

Other funds holding ACLS

Mascoma Wealth Management's ACLS Position: Q3 2024 in Review

Mascoma Wealth Management sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 35 shares — an estimated $4.98K sold.

Mascoma Wealth Management first reported a position in ACLS in Q4 2022 and held it in 7 quarters. The position peaked at $6.21K in Q2 2023. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Mascoma Wealth Management reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Mascoma Wealth Management sold 35 Axcelis shares in Q3 2024, an estimated $4.98K.
  • Mascoma Wealth Management first reported a position in Axcelis in Q4 2022 and held it in 7 quarters.
  • Mascoma Wealth Management's Axcelis position peaked at $6.21K in Q2 2023.
  • 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Mascoma Wealth Management's 13F filing for Q3 2024, filed 5 Nov 2024.